Načítá se...
The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a progressive disease that can eventually lead to complications including acute urinary retention (AUR) and the need for BP...
Uloženo v:
| Vydáno v: | Asian J Urol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Second Military Medical University
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5780290/ https://ncbi.nlm.nih.gov/pubmed/29379733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2017.11.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|